Balda Aktiengesellschaft

EANS-News: Balda AG receives request to convene an Extraordinary General Meeting (with document)

  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.

Company Information

Bad Oeynhausen (euro adhoc) - Bad Oeynhausen, 3 April 2013 - Balda AG announces
that today it received a request from the shareholder Elector GmbH, Berlin,
Germany, to convene an Extraordinary General Meeting in accordance with Section
122 (1) of the German Stock Corporation Act (AktG). The purpose of this meeting
will be to completely replace its three-member Supervisory Board with the
removal of the Supervisory Board Chairman, Dr. Michael Naschke, and the election
of rival candidates for the Supervisory Board members Irene Schetelig and
Wilfried Niemann. The request for Dr. Michael Naschke's removal from office is
motivated inter alia by the fact that he, along with the other two acting
Supervisory Board members, had approved the Management Board's proposal to pay a
special dividend of EUR 1.50 for the current financial year 2012/2013. The
Management Board will examine the legal aspects of the request comprehensively
before deciding what action to take. 
Dr. Michael Naschke's Supervisory Board position had been confirmed at the
Annual General Meeting of Balda AG on 7 November 2012 with 88% of the vote. As
announced by Balda AG, on 22 February 2013 the Bad Oeynhausen Local Court
appointed Ms. Schetelig and Mr. Niemann as independent Supervisory Board members
at the company's request after two Supervisory Board members had resigned from
office with effect from 28 February 2013. The Local Court had rejected the
request from Elector GmbH to appoint two of its own candidates, Dr. Thomas van
Aubel, managing partner of the shareholder Elector GmbH, and Ms. Frauke Vogler,
on the grounds of these candidates' lack of independence. 
Elector GmbH is proposing that the Extraordinary General Meeting elect the
following candidates for the Supervisory Board positions: Dr. Thomas van Aubel,
Ms. Frauke Vogler and Mr. Oliver Oechsle.

About Balda
Balda is a provider of first-class solutions for demanding, high-quality
applications in the fields of medical technology, optics, the automotive
industry and other specialist industrial sectors.
The Group's Balda Medical and Balda Technical operating divisions have
operations worldwide, and the company maintains production facilities in
Germany, the USA and Malaysia. The success of Balda, which employs more than
1,700 people, is based on the deployment of leading-edge, cost-effective
technologies, coupled with the trust-based collaboration with customers. The
Balda AG share (ISIN: DE0005215107) is listed on the SDAX segment of Deutsche

Attachments with Announcement:

Further inquiry note:
Frank Elsner
Frank Elsner Kommunikation für Unternehmen GmbH
Tel.: +49 - 54 04 - 91 92 0
Fax: +49 - 54 04 - 91 92 29

end of announcement                               euro adhoc 

Attachments with Announcement:

company:     Balda Aktiengesellschaft
             Bergkirchener Str.  228 
             D-32549 Bad Oeynhausen
phone:       +49 (0) 5734 9 22-0
FAX:         +49 (0) 5734  922-2604
sector:      Semiconductors & active components
ISIN:        DE0005215107
indexes:     SDAX, Prime All Share
stockmarkets: free trade: Berlin, München, Hamburg, Düsseldorf, Stuttgart,
             regulated dealing/prime standard: Frankfurt 
language:   English

Weitere Meldungen: Balda Aktiengesellschaft

Das könnte Sie auch interessieren: